Co-Authors
This is a "connection" page, showing publications co-authored by ERICH M STURGIS and KATHERINE A HUTCHESON.
Connection Strength
1.838
-
Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. JAMA Otolaryngol Head Neck Surg. 2021 05 01; 147(5):469-478.
Score: 0.204
-
Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis. Oral Oncol. 2017 03; 66:75-80.
Score: 0.151
-
Feeding Tube Utilization in Patients with Salivary Gland Malignancies. Otolaryngol Head Neck Surg. 2017 01; 156(1):109-117.
Score: 0.148
-
Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol. 2016 06; 57:1-5.
Score: 0.143
-
Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma. Head Neck. 2016 06; 38(6):886-93.
Score: 0.138
-
Early risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy: nodal metastasis and extent of surgery. Arch Otolaryngol Head Neck Surg. 2012 Sep; 138(9):833-9.
Score: 0.112
-
Multivariable analysis of risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy. Head Neck. 2012 Apr; 34(4):557-67.
Score: 0.103
-
Outcomes and adverse events of enlarged tracheoesophageal puncture after total laryngectomy. Laryngoscope. 2011 Jul; 121(7):1455-61.
Score: 0.102
-
Enlarged tracheoesophageal puncture after total laryngectomy: a systematic review and meta-analysis. Head Neck. 2011 Jan; 33(1):20-30.
Score: 0.099
-
Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med. 2023 01; 12(1):569-583.
Score: 0.055
-
Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep. 2022 04 22; 12(1):6662.
Score: 0.054
-
Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck. 2022 04; 44(4):952-963.
Score: 0.054
-
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer. 2021 12 01; 127(23):4470-4480.
Score: 0.052
-
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2021 07 01; 147(7):615-623.
Score: 0.051
-
Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer. 2021 04 15; 127(8):1228-1237.
Score: 0.050
-
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
Score: 0.048
-
Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage. Adv Radiat Oncol. 2020 Sep-Oct; 5(5):929-935.
Score: 0.048
-
Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother Oncol. 2020 07; 148:133-139.
Score: 0.047
-
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol. 2018 04; 28(2):108-113.
Score: 0.041
-
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy. Cancer. 2018 04 01; 124(7):1415-1427.
Score: 0.041
-
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018 01; 126(1):75-80.
Score: 0.040
-
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-367.
Score: 0.035
-
Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer. Head Neck. 2009 May; 31(5):611-7.
Score: 0.022